Alfonso Piciocchi
Overview
Explore the profile of Alfonso Piciocchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
1882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marconi G, Piciocchi A, Audisio E, Papayannidis C, Cerrano M, Minotti C, et al.
Blood Adv
. 2025 Mar;
PMID: 40048742
The standard induction treatment for acute myeloid leukemia (AML) has limited efficacy for patients with non-low-risk AML. We conducted a multicenter study phase 1b/2, GIMEMA AML1718, to investigate the safety...
2.
Bassan R, Chiaretti S, Della Starza I, Santoro A, Spinelli O, Tosi M, et al.
Blood
. 2025 Feb;
PMID: 40009490
The GIMEMA LAL2317 protocol investigated the frontline chemotherapy-blinatumomab combination in adult Philadelphia- CD19+ B-lineage acute lymphoblastic leukemia (Ph- B-ALL) to improve minimal residual disease (MRD) response and clinical outcome. Two...
3.
La Rocca U, Ricci R, Piciocchi A, Barberi W, Oldani E, Dominietto A, et al.
Blood Transfus
. 2025 Feb;
PMID: 39949023
Background: Antibodies directed against donor-specific HLA allele(s)/antigen(s) (DSAs) represent a known risk factor for hematopoietic stem cell transplantation (HSCT) engraftment. Still, the overall management needs to be standardized. Material And...
4.
Fazio F, Gherardini M, Rossi E, Za T, Di Landro F, More S, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941726
Background/objectives: Treatments for multiple myeloma (MM) have expanded in the last decade, and the overall survival (OS) of MM patients (pts) is in continuous improvement. With the availability of new...
5.
Messina M, Piciocchi A, Siena L, Soddu S, Buccisano F, Mecucci C, et al.
EJHaem
. 2024 Dec;
5(6):1274-1277.
PMID: 39691247
Given the limited data on the real-life therapeutic use of feline McDonough sarcoma (FMS)-like tyrosine kinase 3 (FLT3) inhibitors in Italy, we surveyed investigators at 59 Italian hematology centers to...
6.
Tadesse F, Sparano F, Gebremedhin A, Abubeker A, Piciocchi A, Cipriani M, et al.
JCO Glob Oncol
. 2024 Nov;
10:e2400281.
PMID: 39541560
Purpose: Health-related quality of life (HRQoL) is now an important goal of therapy for patients with chronic myeloid leukemia (CML). However, there is paucity of data for patients living in...
7.
Gurnari C, Galossi E, Lumia E, Piciocchi A, Divona M, Casciani E, et al.
Br J Haematol
. 2024 Nov;
206(1):331-336.
PMID: 39533868
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) is a haemato-inflammatory syndrome genetically defined by somatic mutations in the X-linked UBA1 gene, typically Val/Thr/Leu substitutions at the Met41 hotspot. Clinical manifestations...
8.
Voso M, Guarnera L, Lehmann S, Lehmann S, Dohner K, Dohner H, et al.
Blood
. 2024 Nov;
145(2):234-243.
PMID: 39504485
Treatment outcomes for acute promyelocytic leukemia (APL) have improved with the widespread use of targeted therapy with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). Our study aimed to validate...
9.
Breccia M, Cucci R, Marsili G, Castagnetti F, Galimberti S, Izzo B, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Sep;
25(1):e34-e39.
PMID: 39322541
Background: In the last decade, TKIs improved the overall survival (OS) of chronic myeloid leukemia (CML) patients who achieved a deep and sustained molecular response (DMR, defined as stable MR4...
10.
Cicconi L, Bisegna M, Gurnari C, Fanciullo D, Piciocchi A, Marsili G, et al.
Br J Haematol
. 2024 Sep;
205(5):1727-1733.
PMID: 39275865
All-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) represent the standard of care for low-intermediate risk acute promyelocytic leukaemia (APL). Leucocytosis during induction with ATRA-ATO represents a common complication with an...